Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Six months after announcing the $5 billion Project NextGen to develop treatments and vaccines that can “stay ahead of COVID-19,” the U.S. government has awarded 20 contracts that reveal what much of that sum will support. The Department of Health and …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The 2023 Nobel Prize in Physiology or Medicine has been jointly awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19 https://www.nobelprize.org/prizes/medicine/2023/press-release/ The discoveries by the two …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi After the US Food and Drug Administration authorized new monovalent COVID vaccines on early last week, the Centers of Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices backed the decision a day later with a nearly unanimous vote in favour of universal XBB-containing …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from “Eris”, a variant of the Omicron form of the coronavirus, rise around the country. https://www.reuters.com/business/healthcare-pharmaceuticals/new-covid-vaccines-are-way-eris-variant-rises-2023-08-14/ …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years. The roll out is a critical step forward in the fight against one of the leading causes …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi The World Health Organization (WHO) on Thursday launched its mRNA vaccine technology hub in South Africa’s Cape Town, to help poorer countries struggling to gain access to life-saving medication. www.reuters.com/business/healthcare-pharmaceuticals/who-officially-launches-mrna-vaccine-hub-cape-town-2023-04-20/ In 2021, the WHO picked South African biotech firm Afrigen Biologics …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi President Joe Biden’s administration said this week it plans to spend more than $5 billion to stoke development of better coronavirus vaccines and treatments to curb future pandemics. www.science.org/content/article/news-glance-new-us-coronavirus-research-lab-gears-carbon-cost-repurposed-accelerator? Like Operation Warp Speed, its predecessor during the administration of former President …
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi Advisers to the US Centers for Disease Control and Prevention (CDC) has voted in favour of the Bavarian Nordic’s Jynneos vaccine for all adults at risk of mpox during an outbreak. https://www.medscape.com/viewarticle/988606?src=wnl_edit_tpal&uac=398271FG&impID=5194437&faf=1 The panel of outside experts voted unanimously in favour …
CDC votes in favour of mpox vaccine; The latest health stories from around the world Read More »
A team of researchers affiliated with several entities in Thailand, working with two colleagues from the US and two from Canada, has developed an mRNA COVID-19 vaccine that can be safely refrigerated for up to three months before use. The team has named it ChulaCov19. In their paper published in the journal Nature Microbiology, the …
Research in Thailand develops long shelf life COVID-19 vaccine Read More »
A new vaccine against malaria has shown promising preliminary results in a large trial in four African countries, boosting hopes that an additional tool may soon be available to help control the deadly disease. www.science.org/content/article/new-data-buoys-hopes-promising-malaria-vaccine-questions-remain The vaccine, named R21/Matrix-M and developed by researchers at the University of Oxford, produced similarly impressive results in a small trial last …
Vaccine trial against malaria shows promising results Read More »
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues Africa | All rights reserved.
